IL162601A0 - Raf/ras binding proteins, their preparation and use - Google Patents
Raf/ras binding proteins, their preparation and useInfo
- Publication number
- IL162601A0 IL162601A0 IL16260102A IL16260102A IL162601A0 IL 162601 A0 IL162601 A0 IL 162601A0 IL 16260102 A IL16260102 A IL 16260102A IL 16260102 A IL16260102 A IL 16260102A IL 162601 A0 IL162601 A0 IL 162601A0
- Authority
- IL
- Israel
- Prior art keywords
- raf
- preparation
- binding proteins
- ras
- ras binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Compounds Of Unknown Constitution (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01000788 | 2001-12-21 | ||
PCT/EP2002/014663 WO2003054193A2 (en) | 2001-12-21 | 2002-12-20 | Raf/ras binding compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IL162601A0 true IL162601A0 (en) | 2005-11-20 |
Family
ID=8176119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16260102A IL162601A0 (en) | 2001-12-21 | 2002-12-20 | Raf/ras binding proteins, their preparation and use |
Country Status (9)
Country | Link |
---|---|
US (1) | US20050164906A1 (de) |
EP (1) | EP1465996B1 (de) |
JP (1) | JP2005525092A (de) |
AT (1) | ATE413453T1 (de) |
AU (1) | AU2002358780B2 (de) |
CA (1) | CA2469263A1 (de) |
DE (1) | DE60229781D1 (de) |
IL (1) | IL162601A0 (de) |
WO (1) | WO2003054193A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002087424A2 (en) * | 2001-05-02 | 2002-11-07 | Purdue Research Foundation | Treatment and diagnosis of macrophage mediated disease |
US20060204565A1 (en) * | 2003-05-06 | 2006-09-14 | Low Philip S | Conjugates and use thereof |
FR2875136B1 (fr) * | 2004-09-10 | 2007-12-14 | Assist Publ Hopitaux De Paris | Utilisation de la proteine gilz exprimee dans les cellules dendritiques pour moduler la reponse immune specifique d'un antigene |
JP5175723B2 (ja) | 2005-07-05 | 2013-04-03 | パーデュー・リサーチ・ファウンデーション | 単球介在性疾患を治療するための組成物の調製 |
WO2014172639A1 (en) * | 2013-04-19 | 2014-10-23 | Ruga Corporation | Raf kinase inhibitors |
EP3740198A4 (de) * | 2018-01-18 | 2023-08-09 | Fred Hutchinson Cancer Center | Veränderung von entzündungszuständen von immunzellen in vivo durch modulation von zellaktivierungszuständen |
US11524091B2 (en) * | 2018-08-21 | 2022-12-13 | Augusta University Research Institute, Inc. | GILZ formulations for wound healing |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0884385A1 (de) * | 1997-04-28 | 1998-12-16 | Applied Research Systems Ars Holding N.V. | Intrazelluläre Modulatoren für apoptopischen Zelltotwegen |
US6867283B2 (en) * | 2001-05-16 | 2005-03-15 | Technion Research & Development Foundation Ltd. | Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells |
-
2002
- 2002-12-20 DE DE60229781T patent/DE60229781D1/de not_active Expired - Fee Related
- 2002-12-20 EP EP02793099A patent/EP1465996B1/de not_active Expired - Lifetime
- 2002-12-20 AU AU2002358780A patent/AU2002358780B2/en not_active Ceased
- 2002-12-20 AT AT02793099T patent/ATE413453T1/de not_active IP Right Cessation
- 2002-12-20 CA CA002469263A patent/CA2469263A1/en not_active Abandoned
- 2002-12-20 IL IL16260102A patent/IL162601A0/xx unknown
- 2002-12-20 US US10/499,097 patent/US20050164906A1/en not_active Abandoned
- 2002-12-20 WO PCT/EP2002/014663 patent/WO2003054193A2/en active Application Filing
- 2002-12-20 JP JP2003554896A patent/JP2005525092A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2005525092A (ja) | 2005-08-25 |
AU2002358780A1 (en) | 2003-07-09 |
ATE413453T1 (de) | 2008-11-15 |
DE60229781D1 (de) | 2008-12-18 |
EP1465996B1 (de) | 2008-11-05 |
AU2002358780B2 (en) | 2008-03-06 |
US20050164906A1 (en) | 2005-07-28 |
WO2003054193A2 (en) | 2003-07-03 |
EP1465996A2 (de) | 2004-10-13 |
CA2469263A1 (en) | 2003-07-03 |
WO2003054193A3 (en) | 2003-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE267200T1 (de) | Bicyclische kinase inhibitoren | |
MXPA03010207A (es) | Nuevas 4-anilinoquinolin-3-carboxamidas. | |
ID27535A (id) | Turunan pirasola sebagai inhibitor p-38 map kinase | |
MXPA02011320A (es) | Derivados de pirazol triciclico como inhibidores de cinasa. | |
HK1087700A1 (en) | Triazolopyridazines as protein kinases inhibitors | |
DE602004018780D1 (de) | Inhibitoren von thienopyridin- und furopyridinkinase | |
WO2005009389A3 (en) | Anaplastic lymphoma kinase modulators and methods of use | |
IS7965A (is) | Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi | |
WO2005116025A3 (en) | 2-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disorders | |
ATE435210T1 (de) | Tetrahydroisochinolylacetamidderivate zur verwendung als orexinrezeptorantagonisten | |
MXPA05012026A (es) | Compuestos de azaindol como inhibidores de cinasa. | |
WO2001087882A3 (en) | Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors | |
IL179883A0 (en) | 4,6-disubstituted pyrimidine derivatives and pharmaceutical compositions containing the same | |
MXPA05013076A (es) | Compuestos de isoindolina-1-ona como inhibidores de cinasa. | |
WO2005030209A8 (en) | Pyridine derivatives and use thereof as urotensin ii antagonists | |
IL162601A0 (en) | Raf/ras binding proteins, their preparation and use | |
NO20030802D0 (no) | Aminoalkoksybenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte for deres fremstilling og preparater inneholdende de samme | |
WO2005055943A3 (en) | Vinorelbine derivatives | |
SE9904128D0 (sv) | Novel compounds | |
DK1446733T3 (da) | Glycosylphosphatidylinositol indeholdende polypeptider | |
WO2002008227A3 (en) | Bicyclic hydantoin derivatives and combinatorial libraries thereof | |
NO20030801L (no) | Aminoalkenylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte for deres fremstilling og preparater inneholdende de samme | |
WO2006124813A3 (en) | Substituted 7, 8-dihydro-1h-pyrimido [4,5-b] [1,4] diazepin-4-amines as?kinase inhibitors |